MedTrace Logo

Clinical Study to Evaluate the Efficacy of Two Dentifrices for Dentine Hypersensitivity

NCT02371616 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 304

Last updated 2018-04-04

Study results available
· View outcomes & findings →

Summary

An 8 week clinical study to evaluate the ability of an experimental dentifrice containing calcium sodium phosphosilicate and sodium fluoride to provide relief from dentine hypersensitivity compared to a marketed dentifrice containing calcium sodium phosphosilicate and sodium monofluorophosphate.

Conditions

  • Dentine Sensitivity

Interventions

DEVICE

Calcium sodium phosphosilicate

5% w/w calcium sodium phosphosilicate

OTHER

Sodium fluoride

1426 ppm fluoride as sodium fluoride

OTHER

Sodium monofluorophosphate

1426 ppm fluoride as sodium monofluorophosphate

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-29
Primary Completion
2014-12-18
Completion
2014-12-18

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02371616 on ClinicalTrials.gov